Overall, we did not observe significant immunologic responses based on the pre-specified primary endpoint of an increase of the percentage of CD8+ TILs and/or the ratio of CD8+/CD4+ TILs in colorectal cancer tissue (Table 4). This evidence concerns the gene CD4 and colorectal cancer.